| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/00365549509032725 |
| P698 | PubMed publication ID | 8658064 |
| P2093 | author name string | Widell A | |
| Paulsen O | |||
| Braconier JH | |||
| Engman K | |||
| P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| A pilot study of ribavirin therapy for chronic hepatitis C | Q28318414 | ||
| Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources | Q29620774 | ||
| Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications | Q41015039 | ||
| Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants | Q41084008 | ||
| Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection | Q42631714 | ||
| Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: Comparison with supplementary hepatitis C antibody assays | Q42986031 | ||
| Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone | Q43037990 | ||
| Ribavirin treatment for chronic hepatitis C | Q50590272 | ||
| P433 | issue | 4 | |
| P921 | main subject | hepatitis C | Q154869 |
| ribavirin | Q421862 | ||
| chronic hepatitis C | Q55779873 | ||
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | 325-329 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Infectious Diseases | Q7429961 |
| P1476 | title | Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study | |
| P478 | volume | 27 |
| Q27477946 | Clinical guidelines on the management of hepatitis C |
| Q27469323 | Clinical relevance of hepatitis C virus genotypes |
| Q50587922 | Combination therapy of chronic hepatitis C: an important step but not the final goal! |
| Q34210708 | Combination treatment with interferon and ribavirin for chronic hepatitis C. |
| Q41653261 | Controversies in diagnosis and treatment of hepatitis C. Which patients benefit most from therapy? |
| Q42990339 | Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations |
| Q33951473 | Current therapy for chronic hepatitis C. |
| Q40909898 | Future approaches to treatment of chronic hepatitis B and hepatitis C infection |
| Q43767234 | Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive |
| Q30327314 | Maximizing life's potentials in AIDS: a psychopharmacologic update. |
| Q41157490 | New treatments for chronic viral hepatitis B and C. |
| Q42986315 | Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group |
| Q27473304 | Ribavirin Quantification in Combination Treatment of Chronic Hepatitis C |
| Q36897890 | Sofosbuvir and ABT-450: terminator of hepatitis C virus? |
| Q73497825 | Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies |
| Q41719005 | Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections |
| Q34027571 | Treatment of chronic hepatitis C: impact of combination therapy |
| Q33809537 | Treatment of naive patients with chronic hepatitis C. |
Search more.